Lupin Ranks Among Top 14 in Great Place To Work India's Best Employers 2026
New Delhi: Global pharmaceutical company Lupin Limited has been recognised among India's Best Employers in the Nation Builders Category 2026 by Great Place To Work India, securing a place among the country's Top 14 organisations.
The recognition highlights Lupin's efforts to foster a workplace culture centred on purpose, trust and inclusion, while contributing to nation-building through improved access to healthcare, community development and employee growth.
The Nation Builders category honours organisations that create an impact beyond business performance through employment generation, people development, community advancement and nation-building, while maintaining strong workplace cultures.
Commenting on the recognition, Yashwant Mahadik, President – Global Human Resources, Lupin, said, "We are honored by this recognition, which celebrates the culture our people bring to life every day. At Lupin, we are focused on creating an environment where individuals feel supported, empowered, and connected to a shared purpose. By investing in our people and their growth, we are building a workplace that enables meaningful contributions to patients, communities, and society."
According to the company, organisations in the Nation Builders category are selected through an independent assessment conducted by Great Place To Work India. The evaluation is based on the Trust Index, which measures employee experience, the Culture Audit assessing workplace practices, and eligibility criteria that evaluate an organisation's broader contribution to nation-building.
Lupin said the recognition reflects its people-first philosophy and continued focus on creating value beyond business performance by investing in its workforce and improving patient outcomes.
Headquartered in Mumbai, Lupin is a global pharmaceutical company with a presence in more than 100 markets. Its portfolio includes branded and generic formulations, complex generics, biotechnology products and active pharmaceutical ingredients (APIs). The company has a strong presence in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system and women's health. Lupin operates 15 manufacturing facilities and seven research centres worldwide and employs more than 26,000 people.
